Grand Pharmaceutical Group Limited (0512.HK)
HKD 5.93
(-0.5%)
HKD 5.93
(-0.5%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.54 HKD | -8.47% |
| 2022 | 0.59 HKD | -13.24% |
| 2021 | 0.68 HKD | 30.77% |
| 2020 | 0.52 HKD | 48.57% |
| 2019 | 0.35 HKD | 29.63% |
| 2018 | 0.27 HKD | 28.57% |
| 2017 | 0.21 HKD | 61.54% |
| 2016 | 0.13 HKD | 41.0% |
| 2015 | 0.09 HKD | 3.25% |
| 2014 | 0.09 HKD | 75.79% |
| 2013 | 0.05 HKD | 47.67% |
| 2012 | 0.03 HKD | 22.86% |
| 2011 | 0.03 HKD | -57.51% |
| 2010 | 0.07 HKD | 165.73% |
| 2009 | 0.02 HKD | 232.62% |
| 2008 | -0.02 HKD | 59.7% |
| 2007 | -0.05 HKD | -333.64% |
| 2006 | -0.01 HKD | 90.27% |
| 2005 | -0.11 HKD | 85.33% |
| 2004 | -0.75 HKD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.44 HKD | 0.0% |
| 2023 FY | - HKD | -8.47% |
| 2023 Q2 | 0.29 HKD | 0.0% |
| 2023 Q4 | 0.24 HKD | 0.0% |
| 2022 FY | - HKD | -13.24% |
| 2022 Q2 | 0.20 HKD | 0.0% |
| 2022 Q4 | 0.39 HKD | 0.0% |
| 2021 Q4 | 0.34 HKD | 0.0% |
| 2021 FY | - HKD | 30.77% |
| 2021 Q2 | 0.34 HKD | 0.0% |
| 2020 Q4 | 0.31 HKD | 0.0% |
| 2020 Q2 | 0.21 HKD | 0.0% |
| 2020 FY | - HKD | 48.57% |
| 2019 Q4 | 0.18 HKD | 0.0% |
| 2019 FY | - HKD | 29.63% |
| 2019 Q2 | 0.17 HKD | 0.0% |
| 2018 FY | - HKD | 28.57% |
| 2018 Q2 | 0.13 HKD | 0.0% |
| 2018 Q4 | 0.14 HKD | 0.0% |
| 2017 FY | - HKD | 61.54% |
| 2017 Q2 | 0.09 HKD | 0.0% |
| 2017 Q4 | 0.10 HKD | 0.0% |
| 2016 Q4 | 0.07 HKD | 0.0% |
| 2016 Q2 | 0.05 HKD | 0.0% |
| 2016 FY | - HKD | 41.0% |
| 2015 Q4 | 0.05 HKD | 0.0% |
| 2015 Q2 | 0.04 HKD | 0.0% |
| 2015 FY | - HKD | 3.25% |
| 2014 Q4 | 0.06 HKD | 0.0% |
| 2014 Q2 | 0.03 HKD | 0.0% |
| 2014 FY | - HKD | 75.79% |
| 2013 Q4 | 0.03 HKD | 0.0% |
| 2013 FY | - HKD | 47.67% |
| 2013 Q2 | 0.02 HKD | 0.0% |
| 2012 Q2 | 0.01 HKD | 0.0% |
| 2012 FY | - HKD | 22.86% |
| 2012 Q4 | 0.01 HKD | -0.75% |
| 2012 Q3 | 0.01 HKD | 0.0% |
| 2012 Q1 | 0.01 HKD | 0.0% |
| 2011 Q2 | 0.01 HKD | 0.0% |
| 2011 Q3 | 0.01 HKD | 0.0% |
| 2011 Q4 | 0.01 HKD | 19.64% |
| 2011 FY | - HKD | -57.51% |
| 2011 Q1 | 0.01 HKD | 0.0% |
| 2010 Q1 | 0.03 HKD | 0.0% |
| 2010 Q3 | 0.03 HKD | 0.0% |
| 2010 Q4 | 0.01 HKD | -56.25% |
| 2010 FY | - HKD | 165.73% |
| 2010 Q2 | 0.03 HKD | 0.0% |
| 2009 Q1 | 0.01 HKD | 0.0% |
| 2009 Q3 | 0.01 HKD | 0.0% |
| 2009 Q4 | 0.03 HKD | 216.05% |
| 2009 FY | - HKD | 232.62% |
| 2009 Q2 | 0.01 HKD | 0.0% |
| 2008 Q2 | -0.00 HKD | 0.0% |
| 2008 Q4 | 0.01 HKD | 284.09% |
| 2008 Q1 | -0.00 HKD | 0.0% |
| 2008 FY | - HKD | 59.7% |
| 2008 Q3 | -0.00 HKD | 0.0% |
| 2007 Q1 | -0.01 HKD | 0.0% |
| 2007 Q4 | -0.00 HKD | 63.33% |
| 2007 Q3 | -0.01 HKD | 0.0% |
| 2007 Q2 | -0.01 HKD | 0.0% |
| 2007 FY | - HKD | -333.64% |
| 2006 Q4 | -0.01 HKD | -344.44% |
| 2006 FY | - HKD | 90.27% |
| 2006 Q2 | -0.00 HKD | 0.0% |
| 2006 Q3 | -0.00 HKD | 0.0% |
| 2006 Q1 | -0.00 HKD | 0.0% |
| 2005 Q2 | -0.03 HKD | 0.0% |
| 2005 Q4 | -0.00 HKD | 89.93% |
| 2005 FY | - HKD | 85.33% |
| 2005 Q1 | -0.03 HKD | 0.0% |
| 2005 Q3 | -0.03 HKD | 0.0% |
| 2004 Q2 | -0.19 HKD | 0.0% |
| 2004 Q3 | -0.19 HKD | 0.0% |
| 2004 Q1 | -0.19 HKD | 0.0% |
| 2004 Q4 | -0.03 HKD | 85.89% |
| 2004 FY | - HKD | 0.0% |
| 2003 Q4 | -0.19 HKD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 0.34 HKD | -58.824% |
| Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | 891.789% |
| Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | 4253.846% |
| Qianhai Health Holdings Limited | -0.03 HKD | 1836.334% |
| Lee's Pharmaceutical Holdings Limited | 0.03 HKD | -1801.408% |
| Essex Bio-Technology Limited | 0.49 HKD | -10.204% |
| Tongfang Kontafarma Holdings Limited | -0.01 HKD | 10484.615% |
| PuraPharm Corporation Limited | -0.27 HKD | 300.0% |
| SSY Group Limited | 0.44 HKD | -22.727% |
| JBM (Healthcare) Limited | 0.15 HKD | -260.0% |
| Jacobson Pharma Corporation Limited | 0.12 HKD | -350.0% |
| China Resources Pharmaceutical Group Limited | 0.68 HKD | 20.588% |